Bain Capital Life Sciences Investors, LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$1.5T
Holdings
30
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (30 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 5,831,307 | $480.6B | 31.49% | |
| 2 | AVIRATEA PHARMACEUTICALS, INC. | 5,615,659 | $120.6B | 7.90% | |
| 3 | DVAXDYNAVAX TECHNOLOGIES CORP | 11,771,708 | $116.0B | 7.60% | |
| 4 | —DICERNA PHARMACEUTICALS INC | 3,080,237 | $115.0B | 7.53% | |
| 5 | ARQTARCUTIS BIOTHERAPEUTICS INC. | 3,979,292 | $108.6B | 7.12% | |
| 6 | ANNXANNEXON INC | 3,241,628 | $73.0B | 4.78% | |
| 7 | CCCCC4 THERAPEUTICS, INC. | 1,642,209 | $62.1B | 4.07% | |
| 8 | PHVSPHARVARIS N.V. | 3,180,601 | $59.3B | 3.88% | |
| 9 | —MERSANA THERAPEUTICS INC. | 3,695,667 | $50.2B | 3.29% | |
| 10 | NRIXNURIX THERAPEUTICS INC | 1,284,314 | $34.1B | 2.23% | |
| 11 | CRNXCRINETICS PHARMACEUTICALS | 1,679,701 | $31.7B | 2.07% | |
| 12 | —SYROS PHARMACEUTICALS INC. | 5,785,036 | $31.5B | 2.07% | |
| 13 | SLDBSOLID BIOSCIENCES INC | 7,929,918 | $29.0B | 1.90% | |
| 14 | MRNS*MARINUS PHARMACEUTICALS INC | 1,431,058 | $25.7B | 1.68% | |
| 15 | —APTINYX INC | 8,891,758 | $25.2B | 1.65% | |
| 16 | KYMRKYMERA THERAPEUTICS INC. | 479,605 | $23.3B | 1.52% | |
| 17 | NAUTNAUTILUS BIOTECHNOLOGY INC. | 2,000,000 | $20.2B | 1.32% | |
| 18 | YB4PSAVARA INC | 11,622,598 | $19.8B | 1.29% | |
| 19 | AGLEUSDAEGLEA BIO THERAPEUTICS INC | 2,700,000 | $18.8B | 1.23% | |
| 20 | —BLUEBIRD BIO, INC. | 538,179 | $17.2B | 1.13% | |
| 21 | ASNSUSDX4 PHARMACEUTICALS INC | 2,119,540 | $13.8B | 0.90% | |
| 22 | —BCTG ACQUISITION CORP | 921,790 | $10.5B | 0.69% | |
| 23 | —RESEARCH ALLIANCE CORP II | 1,000,000 | $10.1B | 0.66% | |
| 24 | —ARYA SCIENCES ACQU CORP IV | 700,000 | $7.5B | 0.49% | |
| 25 | —BCLS ACQUISITION CORP | 487,500 | $5.1B | 0.34% | |
| 26 | —PANACEA ACQUISITION CORP II | 500,000 | $5.0B | 0.33% | |
| 27 | —OMEGA ALPHA SPAC | 400,000 | $4.0B | 0.26% | |
| 28 | —FRAZIER LIFESCIENCES ACQU CO | 300,000 | $3.0B | 0.20% | |
| 29 | —JIYA ACQUISITION CORP | 300,000 | $3.0B | 0.20% | |
| 30 | MLTXHELIX ACQUISITION CORP | 250,000 | $2.6B | 0.17% |